|
MMACHC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.019400E-04 |
| Normal-vs-Stage3 |
1.91460999999782E-05 |
| Normal-vs-Stage4 |
2.49770004678851E-09 |
| Stage1-vs-Stage2 |
7.470600E-01 |
| Stage1-vs-Stage3 |
9.475000E-01 |
| Stage1-vs-Stage4 |
8.497600E-01 |
| Stage2-vs-Stage3 |
8.529800E-01 |
| Stage2-vs-Stage4 |
7.130200E-01 |
| Stage3-vs-Stage4 |
8.593600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.14029999571153E-08 |
| Normal-vs-Asian |
4.885500E-02 |
| Caucasian-vs-AfricanAmerican |
3.122000E-01 |
| Caucasian-vs-Asian |
3.675000E-01 |
| AfricanAmerican-vs-Asian |
8.249000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
5.16499998326481E-09 |
| Male-vs-Female |
8.737100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.84220000552105E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62447832963153E-12 |
| Normal-vs-Extreme_Obese |
6.659400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.037200E-01 |
| Normal_Weight-vs-Obese |
5.896000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.702610E-01 |
| Extreme_Weight-vs-Obese |
8.359000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.113780E-01 |
| Obese-vs-Extreme_Obese |
1.196050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.89580000000378E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
9.97819999959404E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.555400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.430000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.366760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.146000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.614620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.455600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.41639955109474E-10 |
| Normal-VS-KIRP CIMP |
7.50244311120696E-12 |
| Normal-VS-Unclassified PRCC |
1.38979999997346E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.294100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.941000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.598300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.436200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.636600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.016100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66711089377714E-12 |
| Normal-vs-N1 |
1.90636395558386E-12 |
| Normal-vs-N2 |
3.890100E-02 |
| N0-vs-N1 |
6.633600E-01 |
| N0-vs-N2 |
3.775800E-01 |
| N1-vs-N2 |
4.493800E-01 |
|
|
